![Carol Stuckley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carol Stuckley
Direktor/Vorstandsmitglied bei
TRANSGENE
Profil
Carol Stuckley is currently an Independent Director at Transgene SA since 2023.
Former roles include Independent Director at Ipsen SA from 2017 to 2021, Independent Director at Epizyme, Inc. from 2021 to 2022, President & Director at Financial Executives International of Fort Worth Chapter, Independent Non-Executive Director at Centessa Pharmaceuticals Plc from 2021 to 2026, Vice President-Finance & Assistant Treasurer at Pfizer Inc., Chief Financial Officer & Senior VP-Finance at Galderma Laboratories LP from 2010 to 2013, and Chief Financial Officer & Senior Vice President at Healthcare Payment Specialists LLC from 2015 to 2019.
Education includes an undergraduate degree from the University of Delaware in 1977, and graduate degrees including an MBA from Fox School of Business in 1979 and 1980.
Aktive Positionen von Carol Stuckley
| Unternehmen | Position | Beginn |
|---|---|---|
| TRANSGENE | Direktor/Vorstandsmitglied | 05.05.2023 |
Ehemalige bekannte Positionen von Carol Stuckley
| Unternehmen | Position | Ende |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Direktor/Vorstandsmitglied | 24.06.2026 |
| EPIZYME, INC. | Direktor/Vorstandsmitglied | 12.08.2022 |
| IPSEN | Direktor/Vorstandsmitglied | 01.08.2021 |
Healthcare Payment Specialists LLC
 Healthcare Payment Specialists LLC Miscellaneous Commercial ServicesCommercial Services Provides payment and reimbursement solutions | Finanzdirektor/CFO | 01.07.2019 |
Galderma Laboratories LP
 Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Develops and markets dermatology and prescription products | Finanzdirektor/CFO | 01.01.2013 |
Ausbildung von Carol Stuckley
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galderma Laboratories LP
Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Develops and markets dermatology and prescription products | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Healthcare Payment Specialists LLC
Healthcare Payment Specialists LLC Miscellaneous Commercial ServicesCommercial Services Provides payment and reimbursement solutions | Commercial Services |
Fox School of Business
 Fox School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Financial Executives International of Fort Worth Chapter | |
Centessa Pharmaceuticals Plc
 Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
Wählen Sie MarketScreener 
